Entrada Therapeutics
TRDA
TRDA
77 hedge funds and large institutions have $369M invested in Entrada Therapeutics in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
77
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.81M | |
| 2 | +$987K | |
| 3 | +$754K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$733K |
| 5 |
Millennium Management
New York
|
+$680K |
Top Sellers
| 1 | -$5.21M | |
| 2 | -$3.63M | |
| 3 | -$2.6M | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$679K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$331K |